Engaging Patients in Real-World Evidence: An Atrial Fibrillation Patient Advisory Board Case Example
- PMID: 33355917
- PMCID: PMC7884300
- DOI: 10.1007/s40271-020-00479-8
Engaging Patients in Real-World Evidence: An Atrial Fibrillation Patient Advisory Board Case Example
Conflict of interest statement
EMO, SS, and EP are employees of the National Health Council (NHC) who were paid consultants to Pfizer Inc. and Bristol Myers Squibb Company (BMS) in support of focus group preparations and development of the manuscript. NHC is a not-for-profit multi-stakeholder membership organization. As such, it receives membership and sponsorship funds from a variety of organizations and businesses. The lists of members and sponsors can be found at
Similar articles
-
Real-world outcomes, complications, and cost of catheter-based ablation for atrial fibrillation: an update.Curr Opin Cardiol. 2017 Jan;32(1):47-52. doi: 10.1097/HCO.0000000000000348. Curr Opin Cardiol. 2017. PMID: 27755137 Review.
-
[Atrial fibrillation ablation in the real world: the less we know, the more we ablate?].Rev Esp Cardiol (Engl Ed). 2012 Jul;65 Suppl 2:22-8. doi: 10.1016/j.recesp.2012.07.007. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22921171 Review. Spanish.
-
A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.BMC Cardiovasc Disord. 2017 Jul 27;17(1):204. doi: 10.1186/s12872-017-0634-y. BMC Cardiovasc Disord. 2017. PMID: 28750608 Free PMC article.
-
Warfarin for prevention of thromboembolism in atrial fibrillation: comparison of patient characteristics and outcomes of the "Real-World" Michigan Anticoagulation Quality Improvement Initiative (MAQI2) registry to the RE-LY, ROCKET-AF, and ARISTOTLE trials.J Thromb Thrombolysis. 2018 Oct;46(3):316-324. doi: 10.1007/s11239-018-1698-y. J Thromb Thrombolysis. 2018. PMID: 29948756
-
Clinical characteristics, management and outcomes of patients with acute coronary syndrome and atrial fibrillation: real-world data from two nationwide registries in Italy.J Cardiovasc Med (Hagerstown). 2020 Feb;21(2):99-105. doi: 10.2459/JCM.0000000000000911. J Cardiovasc Med (Hagerstown). 2020. PMID: 31923052
Cited by
-
Engaging patient partners to identify research priorities for atrial fibrillation: Results from a patient engagement day.PEC Innov. 2025 Jun 27;7:100417. doi: 10.1016/j.pecinn.2025.100417. eCollection 2025 Dec. PEC Innov. 2025. PMID: 40686554 Free PMC article.
-
Patient-Focused Drug Development and Real World Study.Integr Med Res. 2025 Mar;14(1):101119. doi: 10.1016/j.imr.2024.101119. Epub 2024 Dec 27. Integr Med Res. 2025. PMID: 39935619 Free PMC article. Review.
-
Co-creating tools for embedding meaningful patient and public involvement and engagement in real-world data and evidence research in the pharmaceutical industry setting: a multistakeholder participatory co-design study.BMJ Open. 2025 Feb 17;15(2):e088914. doi: 10.1136/bmjopen-2024-088914. BMJ Open. 2025. PMID: 39961721 Free PMC article.
References
-
- Food and Drug Administration. Real World Evidence. https://www.fda.gov/scienceresearch/specialtopics/realworldevidence/defa.... Accessed 22 Apr 2019
-
- Food and Drug Administration. FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making. FDA. Published online February 9, 2019. https://www.fda.gov/drugs/development-approval-process-drugs/fda-patient.... Accessed 29 Apr 2019
-
- Brice C, Isaac C, Jonsson P et al (2016) Patient-powered research networks for relative effectiveness research: results of a pragmatic literature review and desktop research. https://www.imi-getreal.eu/Portals/1/Documents/01%20deliverables/GetReal.... Accessed 3 Apr 2020
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical